Polypeptide derivatives of parathyroid hormone (PTH)
    8.
    发明申请
    Polypeptide derivatives of parathyroid hormone (PTH) 有权
    甲状旁腺激素多肽衍生物(PTH)

    公开(公告)号:US20050272660A1

    公开(公告)日:2005-12-08

    申请号:US11176735

    申请日:2005-07-08

    CPC分类号: C07K14/635 A61K38/00

    摘要: Novel parathyroid hormone (PTH) polypeptide derivatives are disclosed, as are pharmaceutical compositions containing said polypeptides, and synthetic and recombinant methods for producing said polypeptides. Also disclosed are methods for treating mammalian conditions characterized by decreases in bone mass using therapeutically effective pharmaceutical compositions containing said polypeptides. Also disclosed are methods for screening candidate compounds of the invention for antagonistic or agonistic effects on parathyroid hormone receptor action. Also disclosed are diagnostic and therapeutic methods of said compounds.

    摘要翻译: 公开了新型甲状旁腺激素(PTH)多肽衍生物,含有所述多肽的药物组合物以及用于产生所述多肽的合成和重组方法。 还公开了使用含有所述多肽的治疗有效的药物组合物治疗哺乳动物状况的方法,其特征在于骨量减少。 还公开了用于筛选本发明的候选化合物对甲状旁腺激素受体作用的拮抗作用或激动作用的方法。 还公开了所述化合物的诊断和治疗方法。

    Human parathyroid hormone modifications, preparation and use
    9.
    发明申请
    Human parathyroid hormone modifications, preparation and use 失效
    人甲状旁腺激素修饰,制备和使用

    公开(公告)号:US20050203012A1

    公开(公告)日:2005-09-15

    申请号:US10959605

    申请日:2004-10-07

    CPC分类号: C07K14/635 A61K38/00

    摘要: Synthetic and/or recombinant biologically active peptide derivatives of PTH(1-28), comprising a biologically active peptide at least 90% identical to a peptide consisting essentially of the formula: (a)X01ValSerGluIleGlnLeuMetHisAsn(SEQ ID NO:1); LeuGlyLysHisLeuAsnSerMetX02Arg ValGluTrpLeuArgLysLysLeu (b) fragments thereof containing amino acids 1-24, 1-25, 1-26, or 1-27; (c) pharmaceutically acceptable salts thereof; or (d) N- or C-derivatives thereof; wherein: X01 is Ser, Ala or Gly; and X02 is Glu or Arg, provided that said peptide is not hPTH(1-26)NH2, hPTH(1-27)NH2 or hPTH(1-28)NH2.

    摘要翻译: PTH(1-28)的合成和/或重组生物活性肽衍生物,其包含与基本上由下式构成的肽至少90%相同的生物活性肽:

    < colspec colname =“1”colwidth =“14PT”align =“left”/> (a) X ValSerGluIleGlnLeuMetHisAsn (SEQ ID NO:1); LeuGlyLysHisLeuAsnSerMetX Arg ROW> ValGluTrpLeuArgLysLysLeu (b)其含有氨基酸1-24,1 -25,1-26或1-27; (c)其药学上可接受的盐; 或(d)其N-或C-衍生物; 其中:X 0,1是Ser,Ala或Gly; 如果所述肽不是hPTH(1-26)NH 2,hPTH(1-27)NH 2,则X O 2是Glu或Arg, 或HPTH(1-28)NH 2。